Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

Clinical trial NCT07645651 · RECRUITING

Trial details

NCT number: NCT07645651
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Resectable Pancreatic Ductal Adenocarcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma Locally Advanced Pancreatic Ductal Adenocarcinoma

Start date: 2026-09-15
Primary completion: 2027-07-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.